The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...

Medtronic (NYSE:MDT) shares snapped seven straight days of losses as the stock closed 0.85% higher, at $88.98 on Thursday. ...

The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...

Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Medtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...

The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...

In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...

Medtronic's Hypertension business is on the brink of a major expansion, driven by its Simplicity blood pressure procedure.

Medtronic VP Jason Fontana offered advice for other device developers who might one day be looking for their own NCA.

Medtronic has recalled embolization devices ... attach or stay attached to the blood vessel wall during and after procedures, putting patients at risk of thrombosis, stroke and death.